54631-81-1

Basic information

• Product Name: BOC-HYP(BZL)-OH
• Synonyms: (4R)-1-Boc-4-(phenylmethoxy)-L-proline;Boc-Hyp(Bzl)-OH >=98.0% (HPLC);Boc-O-benzyl-L-trans-4-hydroxyproline≥ 98% (HPLC);Boc-L-Hyp(Bzl)-OH·DCHA;Boc-O-benzyl-L-trans-4-hydroxyproline dicyclohexylammonium salt99%;T-BUTYLOXYCARBONYL-O-BENZYL-L-HYDROXYPROLINE;N-ALPHA-T-BUTOXYCARBONYL-O-BENZYL-L-HYDROXYPROLINE;N-ALPHA-T-BUTOXYCARBONYL-O-BENZYL-TRANS-4-HYDROXY-L-PROLINE
• CAS NO: 54631-81-1
• Molecular Formula: C₁₇H₂₃NO₅
• Molecular Weight: 321.37
• Product Categories: Amino Acid Derivatives;Amino Acids;Hydroxyproline [Hyp];Unusual Amino Acids;Boc-Amino acid series
• Mol File: 54631-81-1.mol

Chemical Properties

• Melting Point: ~70 °C
• Boiling Point: 461.342 °C at 760 mmHg
• Flash Point: 232.812 °C
• Appearance: /
• Density: 1.22 g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.557
• Storage Temp.: Store at 0°C
• PKA: 3.75±0.40(Predicted)
• BRN: 5296858
• CAS DataBase Reference: BOC-HYP(BZL)-OH(CAS DataBase Reference)
• NIST Chemistry Reference: BOC-HYP(BZL)-OH(54631-81-1)
• EPA Substance Registry System: BOC-HYP(BZL)-OH(54631-81-1)

Safety Data

• WGK Germany: 3
• Hazardous Substances Data: 54631-81-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
BOC-HYP(BZL)-OH is used as a building block for peptide synthesis, which is essential for the development of peptide-based drugs. The growing peptide drug market demands fast and reliable synthesis methods, making BOC-HYP(BZL)-OH a valuable asset in this field.
Used in Research and Development:
BOC-HYP(BZL)-OH is also utilized in research and development for the creation of novel peptide-based compounds. Its unique properties enable scientists to explore new avenues in drug discovery and design, potentially leading to the development of innovative therapeutics.
Used in Cosmetics Industry:
In the cosmetics industry, BOC-HYP(BZL)-OH can be used as a component in the development of peptide-based skincare products. Its ability to form stable peptide bonds can contribute to the creation of effective anti-aging and skin rejuvenation formulations.
Used in Agricultural Applications:
BOC-HYP(BZL)-OH may also find applications in the agricultural sector, where it can be used to develop peptide-based biopesticides or plant growth regulators. Its role in peptide synthesis can lead to the creation of targeted and environmentally friendly solutions for crop protection and enhancement.

InChI:InChI=1/C17H23NO5/c1-17(2,3)23-16(21)18-10-13(9-14(18)15(19)20)22-11-12-7-5-4-6-8-12/h4-8,13-14H,9-11H2,1-3H3,(H,19,20)/t13-,14+/m1/s1

Upstream product

• 1194032-60-4 (R)-4-benzyloxy-pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester 
• 74-88-4 methyl iodide 
• 24424-99-5 di-tert-butyl dicarbonate 
• 1499-56-5 (R)-4-hydroxy-L-proline ethyl ester 
• 51-35-4 4R-4-hydroxyproline 
• 34619-03-9 tert-butyldicarbonate 
• 136024-60-7 1-(tert-butyl) 2-methyl (2S,4R)-4-(benzyloxy)pyrrolidine-1,2-dicarboxylate 
• 100-39-0 benzyl bromide 
• 74844-91-0 1-tert-butyl 2-methyl (2S,4R)-4-hydroxy-1,2-pyrrolidinedicarboxylate 
• 13726-69-7 (2S,4R)-4-hydroxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid 
• 74844-91-0 (2S,4S)-N-tert-butoxycarbonyl-4-hydroxyproline methyl ester 
• 1332341-02-2 benzyl (2S)-2-Boc-amino-3-(2-oxiranyl)propionate 
• 87250-97-3 2’-methyl-2’-propanyl (1S,4S)-3-oxo-2-oxa-5-azabicyclo[2.2.1]heptane-5-carboxylate 
• 87691-27-8 N-tert-butoxycarbonyl-L-cis-4-hydroxyproline 

Downstream Products

• 148983-10-2 4(S)-Benzyloxy-N-tert-butyl-1-(tert-butyloxycarbonyl) pyrrolidine-2(S)-carboxamide 
• 141806-18-0 Thr-Homotyr-4-OH-Pro-Thr-α-N-(octyloxybenzpyl)-Orn 
• 141806-08-8 Thr-Thr-Homotyr-Pro-Thr-α-N-(octyloxybenzoyl)-Orn 
• 141806-02-2 Pro-Thr-Tyr-4-OH-Pro-Thr-α-N-(octyloxybenzoyl)-Orn 
• 141806-06-6 Pro-Thr-Homotyr-4-OH-Pro-Thr-α-N-(octyloxybenzoyl)-Orn 
• 141806-04-4 4-OH-Pro-Thr-Tyr-4-OH-Pro-Thr-α-N-(octyloxybenzoyl)-Orn 
• 141806-07-7 4-OH-Pro-Thr-Homotyr-4-OH-Pro-Thr-α-N-(octyloxybenzoyl)-Orn 
• 141806-03-3 4-OH-Pro-Thr-Tyr-Pro-Thr-α-N-(octyloxybenzoyl)-Orn 
• 141806-26-0 Thr-Tyr-4-OH-Pro-Thr-α-N-(octyloxybenzoyl)-Orn 
• 135701-67-6 D-Arg-Arg-Pro-Hyp-Gly-Phe-Ser-D-Phe-Leu-Arg 
• 109333-26-8 NPC 567 
• 865303-03-3 (2S,4R)-di-tert-butyl 4-(benzyloxy)pyrrolidine-1,2-dicarboxylate 
• 868759-46-0 (2S,4R)-tert-butyl 4-(benzyloxy)-2-(tosylcarbamoyl)pyrrolidine-1-carboxylate 
• 111104-03-1 4-Hyp(CH₂Ph)-4-Hyp(CH₂Ph) ethyl ester hydrochloride 

Relevant articles and documents

DNA POLYMERASE THETA INHIBITORS

The invention relates to heterocyclic derivatives and their use in the treatment and prophylaxis of cancer, and to compositions containing said derivatives and processes for their preparation.

HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER

The application relates to heterocyclic amide derivatives and their use in the treatment and prophylaxis of cancer, and to compositions containing said derivatives and processes for their preparation. (Formula (I))

HYDROXYPYRROLIDINE-SUBSTITUTED ARYLSULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS

Disclosed are compounds of Formula A, or a salt thereof: (A) Wherein "A1", R1, R2, R3, R6, and R7 are as defined herein, which compounds have properties for blocking Nav 1.7 ion channels fo

Chiral aminophosphines derived from hydroxyproline and their application in allene–imine [4 + 2] annulation

A robust synthetic route from l-hydroxyproline (l-Hyp) to phosphines has established an expandable library of six chiral aminophosphines, which were then applied to the phosphine-catalyzed [4 + 2] allene–imine annulation. The enantioinduction in the annulations—induced by a purely steric effect—were moderate (up to 57% ee). A switch of the reaction site from the γ- to the β′-carbon atom of the allenoate was observed during the annulations performed using sterically demanding chiral phosphines.

N-methyl-D-aspartate receptor modulators and methods of making and using same

Disclosed are compounds having enhanced potency in the modulation of NMDA receptor activity. Such compounds are contemplated for use in the treatment of diseases and disorders, such as learning, cognitive activities, and analgesia, particularly in alleviating and/or reducing neuropathic pain. Orally available formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed.

Bicyclic enol cyclocarbamates inhibit penicillin-binding proteins

Natural products form attractive leads for the development of chemical probes and drugs. The antibacterial lipopeptide Brabantamide A contains an unusual enol cyclocarbamate and we used this scaffold as inspiration for the synthesis of a panel of enol cyclocarbamate containing compounds. By equipping the scaffold with different groups, we identified structural features that are essential for antibacterial activity. Some of the derivatives block incorporation of hydroxycoumarin carboxylic acid-amino d-alanine into the newly synthesized peptidoglycan. Activity-based protein-profiling experiments revealed that the enol carbamates inhibit a specific subset of penicillin-binding proteins in B. subtilis and S. pneumoniae.

LABELED MOLECULAR IMAGING AGENTS AND METHODS OF USE

Imaging agents are described that comprise labeled substrates capable of being introduced into cells via the cystine/glutamate antiporter. The substrates may be used for imaging or detecting oxidative stress in cells by introducing the labeled agents into

Chemoselective synthesis of N-protected alkoxyprolines under specific solvation conditions

N-Protected hydroxyprolines (Hyp) were transformed chemoselectively into alkoxyproline derivatives by direct O-alkylation. The starting Hyp was transformed into the corresponding dianion in a mixture of dimethyl sulfoxide and tetrahydrofuran (1:16 v/v) as solvent. Under these conditions, the carboxy-anion showed reduced nucleophilicity because it was specifically solvated, and the more reactive oxy-anion was selectively alkylated. N-Protected trans-4-alkoxy-, cis-4-alkoxy- and trans-3-alkoxyprolines were thus obtained in a single step in very high overall yields and with complete stability of the stereogenic center configuration. Copyright

Epoxy amino acids produced from allylglycines intramolecularly cyclised to yield four stereoisomers of 4-hydroxyproline derivatives

Derivatives of 2-amino-4-pentenoic acid (allylglycine) were efficiently resolved using Subtilisin or acylase. The side-chain unsaturated bond of the enantiomerically pure amino acid with tert-butoxycarbonyl (Boc) protection was smoothly epoxidized with m-chloroperbenzoic acid. When the Boc protection of the amino group was removed, the amino group intramolecularly attacked the side-chain epoxide, generating compounds with five-membered rings: the 4-hydroxyproline derivatives. Two diastereomeric products were formed through the cyclisation reaction, for example, (2S,4S)-4-hydroxyproline benzyl ester (cis-8) and (2S,4R)-4-hydroxyproline benzyl ester (trans-8) were formed from (2S)-amino acid with a side-chain epoxide. Compound (2S,4S)-4-hydroxyproline benzyl ester (cis-8) was transformed to a lactone (cis-hydroxyproline lactone, 10) with the removal of benzyl alcohol. The cis-conformation was essential for the intramolecular ester exchange reaction; in fact, no lactone formation was observed for the trans isomer (trans-8). The separation of cis-hydroxyproline lactone and the trans-isomeric hydroxyproline benzyl ester was facile and clear, in contrast to the difficult separation of cis- and trans-hydroxyproline derivatives. Thus, two diastereomers of hydroxyproline derivatives for l-hydroxyproline and also for d-hydroxyproline were obtained, i.e., four diastereomers of hydroxyproline derivatives.

PYRROLOTRIAZINONE DERIVATIVES AS PI3K INHIBITORS

New pyrrolotriazinone derivatives having the chemical structure of formula (I) are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Phosphoinositide 3-Kinases (PI3Ks).